申请人:SmithKline Beecham Corporation
公开号:US20020065230A1
公开(公告)日:2002-05-30
The present invention provides bis-aminomethylcarbonyl compounds that are inhibitors of cysteine and serine proteases. The compounds are particularly useful for treating diseases in which excess cysteine protease activity has been implicated, including osteoporosis, periodontitis and arthritis.
本发明提供了一种双氨甲基羰基化合物,它们是半胱氨酸和丝氨酸蛋白酶的抑制剂。这些化合物特别适用于治疗过多半胱氨酸蛋白酶活性已被指认的疾病,包括骨质疏松症、牙周炎和关节炎。